BRIEF-Amgen and UCB say FDA accepts biologics license application for romosozumab By: Reuters: Company News September 26, 2016 at 16:46 PM EDT * Amgen and UCB announce FDA acceptance of biologics license application for romosozumab Read More >> Related Stocks: Amgen